ロード中...
Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson’s disease
Parkinson’s disease (PD) is a progressive neurological disorder predominantly characterized by motor symptoms including bradykinesia and resting tremor. The gold standard of treatment for PD remains dopamine replacement therapy, which eventually fails due to continued progression of the disease and...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3603000/ https://ncbi.nlm.nih.gov/pubmed/23526920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nmt.12.6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|